Crohn's disease successfully treated with infliximab in a patient receiving hemodialysis: case report and review of the literature
- PMID: 25101989
- PMCID: PMC4602446
- DOI: 10.1097/MD.0000000000000054
Crohn's disease successfully treated with infliximab in a patient receiving hemodialysis: case report and review of the literature
Abstract
There is limited information in the use of antitumor necrosis factor α, infliximab, in patients on hemodialysis. In Crohn's disease (CD), only 3 cases are reported.A 76-year-old man on hemodialysis for renal failure caused by immunoglobulin A nephropathy developed diarrhea and abdominal pains. A marked edema was observed in the pretibia and ankle. An increase of C-reactive protein (CRP) and erythrocyte sedimentation rate, hypoalbuminemia, hypocholesterolemia, and moderate anemia was found. Ultrasonography and computed tomography (CT) found wall thickness in the left colon. Sigmoidoscopy revealed multiple ulcers in the sigmoid colon and noncaseating epithelioid granuloma was found in the biopsy specimen. Barium enema study exhibited collar button signs and longitudinal ulcers in the left colon.A severe form of CD was diagnosed. Metronidazole seemed to decrease CRP but was ineffective in ameliorating diarrhea. Infliximab rather than steroid hormone was chosen for the treatment. Standard induction therapy with infliximab was initiated. Symptoms rapidly improved then disappeared. CD activity index decreased from 747 to a remission level of 134 after 2 infusions of infliximab. Scheduled maintenance infliximab therapy was administered after the induction therapy. Ultrasonography and CT showed a disappearance of the wall thickness of the colon. Adverse reactions were not observed.Infliximab was effective and safe in a patient with CD on hemodialysis. Our case has added additional literature in accordance with previous reports supporting infliximab as effective and safe in patients on hemodialysis.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures



Similar articles
-
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5. Acta Dermatovenerol Croat. 2016. PMID: 27149138
-
[A case of Crohn's disease having normal delivery after infliximab treatment during early pregnancy].Korean J Gastroenterol. 2013 Jan 25;61(1):37-41. doi: 10.4166/kjg.2013.61.1.37. Korean J Gastroenterol. 2013. PMID: 23354348 Korean.
-
Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series.Rev Esp Enferm Dig. 2011 Jun;103(6):294-8. doi: 10.4321/s1130-01082011000600003. Rev Esp Enferm Dig. 2011. PMID: 21736395 Clinical Trial.
-
Systemic lupus erythematosus complicated by Crohn's disease: a case report and literature review.BMC Gastroenterol. 2012 Dec 5;12:174. doi: 10.1186/1471-230X-12-174. BMC Gastroenterol. 2012. PMID: 23216789 Free PMC article. Review.
-
Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.J Gastrointestin Liver Dis. 2013 Sep;22(3):333-6. J Gastrointestin Liver Dis. 2013. PMID: 24078992 Review.
Cited by
-
[Dosage and toxicity of antirheumatic drugs in renal insufficiency].Z Rheumatol. 2015 May;74(4):300-9. doi: 10.1007/s00393-014-1480-2. Z Rheumatol. 2015. PMID: 25962451 Review. German.
-
Ulcerative Colitis Presented as Fever and Bloody Diarrhea at Initiation of Dialysis in an Elderly Patient with End-Stage Kidney Disease.Case Rep Med. 2015;2015:725205. doi: 10.1155/2015/725205. Epub 2015 Nov 4. Case Rep Med. 2015. PMID: 26617642 Free PMC article.
-
Association between Crohn's disease and AarF domain-containing kinase 4 glomerulopathy.Clin J Gastroenterol. 2019 Jun;12(3):263-268. doi: 10.1007/s12328-019-00937-3. Epub 2019 Jan 31. Clin J Gastroenterol. 2019. PMID: 30706428
-
Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide.Aliment Pharmacol Ther. 2025 Aug;62(4):400-418. doi: 10.1111/apt.70262. Epub 2025 Jul 2. Aliment Pharmacol Ther. 2025. PMID: 40601470 Free PMC article. Review.
-
Efficacy of vedolizumab as maintenance therapy in a patient with ulcerative colitis receiving haemodialysis in end-stage kidney failure: A case report.SAGE Open Med Case Rep. 2023 Apr 10;11:2050313X231165641. doi: 10.1177/2050313X231165641. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37063436 Free PMC article.
References
-
- Karampetsou MP, Liossis SN, Sfikakis PP. TNF-α antagonists beyond approved indications: stories of success and prospects for future. QJM. 2010;103:917–928. - PubMed
-
- Tokayer AZ, Brandt LJ. Idiopathic inflammatory bowel diseases in the elderly. In: Inflammatory Bowel Disease. Philadelphia, PA: W.B. Saunders; 2000:335–341.
-
- Lichtenstein GR, Hanauer SB, Sandborn WJ. The Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104:465–483. - PubMed
-
- Chiba M, Sugawara T, Tsuda H, et al. Esophageal ulcer of Crohn’s disease: disappearance in 1 week with infliximab. Inflamm Bowel Dis. 2009;15:1121–1122. - PubMed
-
- Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med. 2001;135:27–31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous